Patents
Patents for C07C 317 - Sulfones; Sulfoxides (15,874)
12/2003
12/04/2003WO2003099772A1 Phenylcyclohexylpropanolamine derivatives, preparation and therapeutic application thereof
12/04/2003WO2003099409A1 Method for producing specific crystalline modifications of polymorphous substances
12/04/2003WO2003072062A3 Amino-substituted (e)-2,6-dialkoxystyryl 4-substituted benzylsulfones for treating proliferative disorders
12/04/2003WO2002049641A3 Anti-endoparasitic amidoacetonitrils
12/04/2003US20030225285 Oxidizing a protected aminoalcohol to a chiral protected aminoaldehyde and diastereoselectively forming the aminoepoxide from said aminoaldehyde with an organometallic methylene-adding reagent in an appropriate solvent
12/04/2003US20030225158 Compounds that modulate PPAR activity and methods for their preparation
12/04/2003US20030225091 Aryl carboxylic acids and tetrazoles for treating diabetes, especially type II diabetes
12/04/2003US20030225075 Novel pyrimidone derivatives
12/04/2003US20030225074 E.g., 2-((4'-Methoxy(1,1'-biphenyl)-4-yl)sulfonyl)amino-4-hydroxy-5-((2 -thiazolyl)thio)-pentanoic Acid
12/04/2003US20030224298 Novel sulfonyldiazomethanes, photoacid generators, resist compositions, and patterning process
12/04/2003CA2784937A1 Ccr9 inhibitors and methods of use thereof
12/04/2003CA2486651A1 Sulfone liver x-receptor modulators
12/03/2003EP1366024A2 Sulfoxide and bis-sulfoxide compounds and compositions for cholesterol management and related uses
12/03/2003EP1366021A2 Substituted diarylureas as stimulators for fas-mediated apoptosis
12/03/2003EP1366008A2 Method for producing monocarbonyl compounds or biscarbonyl compounds or hydroxyl compounds
12/03/2003CN1460097A NF-kB inhibitor containing substituted benzoic acid derivative as active ingredient
12/03/2003CN1129576C Phenyl heterocyclic compound used as epoxy enzyme-2 inhibitor
12/02/2003US6657086 For reducing weight in mammals; preventing and treating obesity
12/02/2003US6656954 Such as N-hydroxy-2-(((4-phenoxyphenyl)-sulfonyl)methyl) benzamide which inhibits matrix metalloprotease activity
11/2003
11/27/2003WO2003097590A1 Method for producing bicalutamide
11/27/2003WO2003097568A1 Process for producing 4-phenyl-4-oxo-2-butenoic ester derivative
11/27/2003WO2003006425A3 Novel compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents
11/27/2003WO2002057242A3 Urea derivatives as integrin alpha 4 antagonists
11/27/2003US20030220468 Modified forms of pharmacologically active agents and uses therefor
11/27/2003US20030220371 Administering to a mammal an aromatic or heteroaromatic ring substituted triazole derivative to treat the conditions mediated by angiogenesis, such as cancer, haemangioma, proliferative retinopathy, rheumatoid arthritis, and obesity
11/27/2003US20030220350 For example, 3-(4-((N-(5-chlorobenzo(B)thiophen-3-carbonyl)-N-(2,2-diphenyl ethyl)amino)methyl)benzoylamino)propionic acid; for treatment or prevention of glucagon-mediated diseases such as diabetes
11/27/2003US20030220315 Such as 3',3"-dibromo-4',4"-dimethoxy-5',5"-bis-(methoxycarbonyl)-1,1 -diphenylethene; for treating viral diseases/retroviruses
11/27/2003US20030220228 Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and methods of use
11/27/2003CA2468426A1 Process for preparing n-(4'-cyano-3'-trifluoromethylphenyl)-3-(4"-fluorophenylsulfonyl)-2-hydroxy-2-methylpropionamide
11/26/2003EP1363878A1 Process for preparing sulfamoyl-substituted phenethylamine derivatives
11/26/2003EP1091933B1 Substituted beta-diketones and their use
11/26/2003CN1458146A Casodex synthesizing process for anti-tumour medicine
11/26/2003CN1458145A Process for purifying high purity dimethyl sulfoxide, and dimethyl sulfoxide and amine mixture
11/25/2003US6653483 Alkyl or aryl substituted dihydronaphthalene derivatives having retinoid and/or retinoid antagonist-like biological activity
11/25/2003US6653309 Binding ligands
11/25/2003CA2064349C Stereoisomeric enrichment of 2-amino-3-hydroxy-3-phenylpropionic acids
11/20/2003WO2003095424A1 Process for producing shogaol and intermediates for the synthesis thereof
11/20/2003WO2003095423A1 A process for the preparation of modafinil
11/20/2003WO2003095422A2 Catalytic process for preparing perfluoroethanesulfonyl fluoride and/or perfluorodiethylsulfone
11/20/2003WO2002002506A8 Compounds to treat alzheimer's disease
11/20/2003WO2002002505A8 Compounds to treat alzheimer's disease
11/20/2003US20030216580 Herbicide active materials
11/20/2003US20030216572 Process to produce oxazolidinones
11/20/2003US20030216535 (E)-styryl sulfone anticancer agents
11/20/2003US20030216434 Cyclic derivatives as modulators of chemokine receptor activity
11/20/2003CA2485428A1 A process for the preparation of modafinil
11/19/2003EP1362846A1 Aminoethanol derivatives
11/19/2003EP0973392B1 Sulfonyl divalent aryl or heteroaryl hydroxamic acid compounds
11/19/2003EP0809499B1 Certain 1,4,5-tri-substituted imidazole compounds useful as cytokine
11/19/2003CN1128015C Noncrystalline alloy catalyst for hydrogenation of cyclobutene sulphone and preparation and use thereof
11/18/2003US6649657 Prevention of loss and restoration of bone mass by certain prostaglandin agonists
11/18/2003US6649629 Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and methods of use
11/18/2003US6649616 For therapy and prophylaxis of cardiovascular disorders caused by ischaemia
11/13/2003WO2003093221A1 Preparation of d-(-) -1-substituted phenyl-2-dichloro-acetoamino-3fluoro-1-propanol from l type substituted phenyl serine ester
11/13/2003WO2002098849A3 Hydroxy alkyl amine derivatives as beta-secretase inhibitors and their use for the treatment of alzheimer’s disease and similar diseases
11/13/2003WO2002002520A8 Compounds to treat alzheimer's disease
11/13/2003WO2001040188A8 Curcumin analogues for treating cancer
11/13/2003US20030212067 Bone disorders; rheumatic diseases; wound healing agents
11/13/2003US20030211421 Optically active compound and photosensitive resin composition
11/12/2003CN1455768A Process for producing diphenyl sulfone compound
11/12/2003CN1455767A Substituted phenylcyclohexane carboxylic acid amides and use thereof
11/12/2003CN1127479C Sulfonyl urea derivatives ad their use in control of interleukin-1 activity
11/11/2003US6646010 α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
11/11/2003US6645992 Malonamid and malonamic ester derivatives with antithrombotic activity, their preparation, and their use
11/11/2003CA2052800C Aryl sulphide, aryl sulphoxide and aryl sulphone compounds and processes for their preparation
11/06/2003WO2003091207A2 Method of preparing amine stereoisomers
11/06/2003WO2003091206A1 Process for producing dihydroxydiphenyl sulfone
11/06/2003WO2003091204A1 Phenethanolamine derivatives
11/06/2003WO2002051983A3 Novel compounds and compositions as cathepsin inhibitors
11/06/2003US20030208018 A copolymer comprising a monomer of tosylethylmethacrylate having high absorbency at the 193 nm wavelength; forming ultrafine patterns during photolithography process
11/06/2003US20030207894 1,4-Disubstituted benzenes as insecticides
11/06/2003US20030207889 Metaloenzyme and tumor necrosis factor-alpha converting enzyme inhibitors such as 2-(4-Methoxyphenylsulfonylmethyl)-5-phthalimido-pentanoic acid N-hydroxy amide, used for prophylaxis of degenerative diseases and cancer
11/06/2003US20030207872 Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
11/06/2003CA2482432A1 Method of preparing amine stereoisomers
11/05/2003EP1359143A1 Novel sulfone derivatives and process for producing these
11/05/2003EP1359136A2 Polymeric resin compounds and their preparation
11/04/2003US6642418 Processes for preparing intermediates
11/04/2003US6642416 Process for the preparation of 2-[alkyl(aryl)]sulfonylbenzene-sulfonyl chlorides and their intermediates
11/04/2003US6642410 Useful as antiproliferative agents, including, for example, anticancer agents
10/2003
10/30/2003WO2003047508A3 Paclitaxel solvates
10/30/2003WO2002081432A3 Sulfoxides or sulfones grafted onto polymers
10/30/2003US20030203966 Such as N-(3,5-dimethyl-4-((nitromethyl)sulphonyl) phenyl)benzenesulphonamide for treatment/prevention of peripheral and autonomous neurolgical diabetic complications, renal and ocular disorders (cataracts, retinopathy)
10/30/2003US20030203951 Aromatic or heteroaromatic compounds containing amide group are useful as inhibitor of dihydroorotate dehydrogenase
10/30/2003US20030203297 Comprising charge transport compound, charge generating compound, and electrically conductive substrate over which charge transport composition and charge generating compound are located
10/29/2003EP1357109A2 Process for aryl alkyl sulfide
10/29/2003EP1114025B1 Method for producing derivatives of 4-alkylsulfinyl methylarylene methanols
10/29/2003EP1089964B1 Hydrazine derivatives
10/29/2003CN1452612A Process for preparing carotenoid polyene chain compounds and intermediates for preparing same
10/28/2003US6638979 Imidamide derivatives
10/28/2003US6638962 Cycloheptene compounds
10/28/2003US6638952 Aromatic sulfonyl alpha-cycloamino hydroxamic acid compounds
10/28/2003US6638931 Aminoguanidines and alkoxyguanidines as protease inhibitors
10/23/2003WO2003087066A1 α,β-UNSATURATED HYDROXAMIC ACID DERIVATIVES AND THEIR USE AS HISTONE DEACETYLASE INHIBITORS
10/23/2003WO2003087026A1 2-(2,6-dichlorophenyl)-diarylimidazoles
10/23/2003WO2003007954A3 Sulfonyl aryl hydroxamates and their use as matrix metalloprotease inhibitors
10/23/2003US20030199708 Process for the preparation of cyclic diketones
10/23/2003US20030199701 Treating under hydrolyzing conditions a hydantoin compound to form an alpha-amino acid derivative
10/23/2003US20030199698 Anticoagulants such as 2'-tert-butylaminosulfonylbiphenyl-4-yl-(3-(5-methyl-1,2,4-oxadiazol-3 -yl)benzyl)(2-cyanoethyl) carbamate, used for prophylaxis of cardiovascular disorders
10/23/2003US20030199691 2-(2,6-dichlorophenyl)-diarylimidazoles
10/23/2003US20030199579 Ectoparasitic insect pest controllers for animals and their usage
1 ... 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 ... 159